Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Promising Innovative Medicine

- PMLiVE

Britain facing social care ‘time bomb’

Raising awareness of financial realities is key first step, Astellas Debate hears

- PMLiVE

How AbbVie Care is putting patients at the centre

And why this is good news for everyone

Shire Basingstoke

Shire launches long-acting ADHD drug Intuniv in UK

Also plans to launch the once-daily treatment in Japan later this year

ABPI London offices

UK pharma’s contribution to NHS hits £1bn mark

ABPI says local access to new treatments still not universal despite drug rebates

- PMLiVE

The growing necessity for pharma to become a true health delivery partner of the NHS

Focus on solving your customer’s biggest problems to create shared value

- PMLiVE

New UK Cancer Drugs Fund takes shape

NICE to manage access to cancer treatments from 1 July

- PMLiVE

Sustainable solutions

Bayer's Alex Moscho on working towards long-term answers in healthcare

- PMLiVE

Amgen’s roll-out of myeloma drug Kyprolis reaches UK

Company hopes to gain NICE approval later this year

- PMLiVE

Researchers say ‘neurostatins’ may ward off Alzheimer’s

Preclinical studies show bexarotene prevents nerve cell degeneration

Eli Lilly HQ

UK court backs Actavis in dispute over Lilly’s Alimta

Actavis’ generic version ruled not to infringe Lilly’s intellectual property

- PMLiVE

UK government fines GSK over ‘pay-for-delay’ deals

Merck KGaA and Actavis also fined for their involvement

- PMLiVE

UK moves to accelerate digital health uptake

Aims to make London the global capital of digital health technologies

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links